Compile Data Set for Download or QSAR
Report error Found 37 Enz. Inhib. hit(s) with all data for entry = 247
TargetInterleukin-17F(Human)
Innov17

US Patent
LigandPNGBDBM247030(5-(1H-pyrazol-4-yl)-1-((1-(pyridin-3-ylsulfonyl)pi...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17A(Human)
Innov17

US Patent
LigandPNGBDBM247030(5-(1H-pyrazol-4-yl)-1-((1-(pyridin-3-ylsulfonyl)pi...)
Affinity DataIC50: 1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-21(Human)
Innov17

US Patent
LigandPNGBDBM247029(1-((1-(4-chlorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-22(Human)
Innov17

US Patent
LigandPNGBDBM247029(1-((1-(4-chlorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17F(Human)
Innov17

US Patent
LigandPNGBDBM247029(1-((1-(4-chlorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17A(Human)
Innov17

US Patent
LigandPNGBDBM247029(1-((1-(4-chlorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: 1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-21(Human)
Innov17

US Patent
LigandPNGBDBM247028(1-((5,5-dimethyl-1-(phenylsulfonyl)pyrrolidin-3-yl...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17F(Human)
Innov17

US Patent
LigandPNGBDBM247028(1-((5,5-dimethyl-1-(phenylsulfonyl)pyrrolidin-3-yl...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17F(Human)
Innov17

US Patent
LigandPNGBDBM247032(rac.-cis-1-((-5-methyl-1-(phenylsulfonyl)pyrrolidi...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17A(Human)
Innov17

US Patent
LigandPNGBDBM247032(rac.-cis-1-((-5-methyl-1-(phenylsulfonyl)pyrrolidi...)
Affinity DataIC50: 1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-21(Human)
Innov17

US Patent
LigandPNGBDBM247031(1-((1-(2-fluorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-22(Human)
Innov17

US Patent
LigandPNGBDBM247031(1-((1-(2-fluorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17F(Human)
Innov17

US Patent
LigandPNGBDBM247031(1-((1-(2-fluorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17A(Human)
Innov17

US Patent
LigandPNGBDBM247031(1-((1-(2-fluorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: 1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-21(Human)
Innov17

US Patent
LigandPNGBDBM247030(5-(1H-pyrazol-4-yl)-1-((1-(pyridin-3-ylsulfonyl)pi...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-22(Human)
Innov17

US Patent
LigandPNGBDBM247030(5-(1H-pyrazol-4-yl)-1-((1-(pyridin-3-ylsulfonyl)pi...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-21(Human)
Innov17

US Patent
LigandPNGBDBM247034(1-((1-(methylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-22(Human)
Innov17

US Patent
LigandPNGBDBM247034(1-((1-(methylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17F(Human)
Innov17

US Patent
LigandPNGBDBM247034(1-((1-(methylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17A(Human)
Innov17

US Patent
LigandPNGBDBM247034(1-((1-(methylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: 1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-21(Human)
Innov17

US Patent
LigandPNGBDBM247033(rac.-trans-1-((-5-methyl-1-(phenylsulfonyl)pyrroli...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17F(Human)
Innov17

US Patent
LigandPNGBDBM247033(rac.-trans-1-((-5-methyl-1-(phenylsulfonyl)pyrroli...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17A(Human)
Innov17

US Patent
LigandPNGBDBM247033(rac.-trans-1-((-5-methyl-1-(phenylsulfonyl)pyrroli...)
Affinity DataIC50: 1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-21(Human)
Innov17

US Patent
LigandPNGBDBM247032(rac.-cis-1-((-5-methyl-1-(phenylsulfonyl)pyrrolidi...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17F(Human)
Innov17

US Patent
LigandPNGBDBM247023(US9701663, 6)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17A(Human)
Innov17

US Patent
LigandPNGBDBM247023(US9701663, 6)
Affinity DataIC50: 1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-21(Human)
Innov17

US Patent
LigandPNGBDBM247010(1-((1-(phenylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17F(Human)
Innov17

US Patent
LigandPNGBDBM247010(1-((1-(phenylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17A(Human)
Innov17

US Patent
LigandPNGBDBM247010(1-((1-(phenylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: 1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17A(Human)
Innov17

US Patent
LigandPNGBDBM247028(1-((5,5-dimethyl-1-(phenylsulfonyl)pyrrolidin-3-yl...)
Affinity DataIC50: 1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-21(Human)
Innov17

US Patent
LigandPNGBDBM247027(US9701663, 8)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17F(Human)
Innov17

US Patent
LigandPNGBDBM247027(US9701663, 8)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17A(Human)
Innov17

US Patent
LigandPNGBDBM247027(US9701663, 8)
Affinity DataIC50: 1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-21(Human)
Innov17

US Patent
LigandPNGBDBM247026(US9701663, 7)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17F(Human)
Innov17

US Patent
LigandPNGBDBM247026(US9701663, 7)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-17A(Human)
Innov17

US Patent
LigandPNGBDBM247026(US9701663, 7)
Affinity DataIC50: 1.00E+4nMAssay Description:Peripheral blood mononuclear cells (PBMCs) were sourced from freshly prepared leukocyte enriched plasma (buffy coat) from healthy donors (New York Bl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetInterleukin-21(Human)
Innov17

US Patent
LigandPNGBDBM247023(US9701663, 6)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent